Light-Controlled Toxicity of Engineered Amyloid β-Peptides
Aggregation of amyloid β (Aβ1–42), causing toxicity, is a critical step in Alzheimer's disease (AD). AD studies are difficult to compare because Aβ1–42 aggregation is poorly controllable under physiological conditions. To control aggregation and toxicity, we engineered light‐switchable Aβ1–42 a...
Saved in:
Published in | Chembiochem : a European journal of chemical biology Vol. 13; no. 18; pp. 2657 - 2660 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
21.12.2012
WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aggregation of amyloid β (Aβ1–42), causing toxicity, is a critical step in Alzheimer's disease (AD). AD studies are difficult to compare because Aβ1–42 aggregation is poorly controllable under physiological conditions. To control aggregation and toxicity, we engineered light‐switchable Aβ1–42 analogues that enable controllable conversion of nontoxic fibrils into toxic oligomers simply by illumination. |
---|---|
Bibliography: | istex:626D17EAF99F728F0632EC3117A339D11362354F ark:/67375/WNG-RHKCHSB6-Z ArticleID:CBIC201200605 |
ISSN: | 1439-4227 1439-7633 |
DOI: | 10.1002/cbic.201200605 |